Ubiquitech Software Corp (OTCMKTS:UBQU) has announced that it would be implementing a new Interactive Voice Response (IVR) system, for its subsidiary HempLife Today. The company has stated that it would develop and implement a 24-hour toll free customer support line, in order to improve customer support and satisfaction, while increasing sales volume. UBQU has further claimed that it has used one of the most advanced software applications, for this purpose.
The company intends to make use of the new system, to offer an easier way to learn about Ubiquitech and its products. Moreover, the move would further enhance customer interaction, with the help of a specialist, who would then take customer orders. Luke Dreyer, the head of operations at UBQU, stated that the new IVR system would provide all the important information, to customers, 24-hours a day. He further pointed out that this would reduce the workload of their live representatives, allowing for detailed customer interactions.
James Ballas, the CEO of Ubiquitech, claimed that the company was getting a large volume of customers and was looking to further increase this number. As such, it made sense to implement a new IVR. He further stated that customer service was one of the top selling points, for UBQU. Mr. Ballas also expressed his confidence in the ability of the system to contribute to the bottom-line growth of the company.
In addition to this, UBQU also issued a guidance for the FY2017, stating that revenues for the period are expected to increase by 55%. The company pointed out that the guidance is based on the internal figures, for the 1Q2017 and March 2017. Moreover, HempLife further claimed that its products continue to gain exposure, while also adding new products to its CannazALL product line. Furthermore, UBQU is also working to educate the general public on the benefits of CBD and hemp derived products.
Ubiquitech Software Corp (OTCMKTS:UBQU) declined by 6.42%, during the March 24 trading session, on a trade volume of 6.15 million, to close at a share price of $0.0204.
Wall Street PR - BIG BUYOUT OPPORTUNITYhttp://wallstreetpr.com
Here’s how to leverage this breakthrough technology…
2017 Most Disruptive Biotech VBIOhttp://www.financialstrend.com
Disruptive biotech VBIO decodes targeted drug delivery for stem cells
Enter The $100 Cannabis Markethttp://www.financialstrend.com
VBIO cannabis industry setup for explosive growth